Caution in adding bevacizumab in the adjuvant treatment of breast cancer
| dc.contributor.author | Ziogas, D. | en |
| dc.contributor.author | Roukos, D. | en |
| dc.date.accessioned | 2015-11-24T19:31:27Z | |
| dc.date.available | 2015-11-24T19:31:27Z | |
| dc.identifier.issn | 1534-4681 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/23265 | |
| dc.rights | Default Licence | - |
| dc.subject | Angiogenesis Inhibitors/*therapeutic use | en |
| dc.subject | Antibodies, Monoclonal/*therapeutic use | en |
| dc.subject | Antibodies, Monoclonal, Humanized | en |
| dc.subject | Antineoplastic Combined Chemotherapy Protocols | en |
| dc.subject | Chemotherapy, Adjuvant | en |
| dc.subject | Colonic Neoplasms/*drug therapy | en |
| dc.subject | Female | en |
| dc.subject | Humans | en |
| dc.subject | Vascular Endothelial Growth Factor A/antagonists & inhibitors | en |
| dc.title | Caution in adding bevacizumab in the adjuvant treatment of breast cancer | en |
| heal.access | campus | - |
| heal.fullTextAvailability | TRUE | - |
| heal.identifier.primary | 10.1245/s10434-009-0798-5 | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/19888632 | - |
| heal.identifier.secondary | http://www.springerlink.com/content/0u2201325m024641/fulltext.pdf | - |
| heal.journalName | Ann Surg Oncol | en |
| heal.journalType | peer-reviewed | - |
| heal.language | en | - |
| heal.publicationDate | 2010 | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.type | journalArticle | - |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: